{
    "2018-02-22": [
        [
            {
                "time": "2018-01-05",
                "original_text": "Look at Eli Lillyâ€™s 4Q17 Revenue",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "4Q17",
                        "Revenue"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-22",
                "original_text": "European ADRs Move Higher in Thursday Trading",
                "features": {
                    "keywords": [
                        "European",
                        "ADRs",
                        "Move Higher",
                        "Thursday Trading"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "international",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-22",
                "original_text": "Health Care Sector Update for 02/22/2018: SGMO, GILD, CLVS, NVO, NVS, BKD",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "SGMO",
                        "GILD",
                        "CLVS",
                        "NVO",
                        "NVS",
                        "BKD"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Novo Nordisk successfully kicks off final-stage trials for first diabetes pill",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "final-stage trials",
                        "diabetes pill"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}